期刊
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 136, 期 52, 页码 18034-18043出版社
AMER CHEMICAL SOC
DOI: 10.1021/ja509513c
关键词
-
资金
- NIH [GM100283-01]
- Bristol-Myers-Squibb [OCR4997.11]
This article reports the design, synthesis, and evaluation of a novel class of molecules of intermediate size (approximately 7000 Da), which possess both the targeting and effector functions of antibodies. These compoundscalled synthetic antibody mimics targeting prostate cancer (SyAM-Ps)bind simultaneously to prostate-specific membrane antigen and Fc gamma receptor I, thus eliciting highly selective cancer cell phagocytosis. SyAMs have the potential to combine the advantages of both small-molecule and biologic therapies, and may address many drawbacks associated with available treatments for cancer and other diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据